Status:
COMPLETED
The Role of ICSI in Non-male Factor Infertility in Advanced Maternal Age
Lead Sponsor:
Dr. Tal Miller-Elkan
Conditions:
Infertility, Female
Eligibility:
FEMALE
39-44 years
Phase:
NA
Brief Summary
The use of Intracytoplasmic sperm injection (ICSI) has increased in the last decades regardless of the cause of infertility. Despite the increased use there is no clear evidence that ICIS is more effe...
Detailed Description
ICSI is a method used in IVF in which a single sperm is injected directly into an oocyte. Originally ICSI was developed as a method for the treatment for couples with severe male factor infertility. I...
Eligibility Criteria
Inclusion
- Women between 39 to 44 years of age undergoing IVF treatments for non-male factor infertility.
Exclusion
- Women undergoing IVF treatments for male factor infertility.
- Cases where PGD is planned.
- Women with a BMI above 40.
- Women younger then 39 years of age or older then 44 years of age.
- Women with a rate of fertilization bellow 50% in previous IVF cycles.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2020
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT03370068
Start Date
January 1 2018
End Date
July 1 2020
Last Update
July 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IVF Unit, Sheba medical Center
Tel Litwinsky, Israel